Clinical Research Directory

Key Inclusion Criteria: 1. Diagnosis of non-infectious anterior, intermediate, posterior or panuveitis (For anterior uveitis, there must be evidence of inflammation affecting the posterior segment), as defined in the protocol 2. Active disease at baseline, as defined in the protocol 3. Part A only: Best Corrected Visual Acuity (BCVA) of ≤65 and \>10 Early Treatment Diabetic Retinopathy Study (ETDRS) letters (Snellen equivalent of worse than or equal to 20/50 and better than 20/630) at the screening visit and on day 1 4. Part B only: BCVA of \<75 and \>10 ETDRS letters (Snellen equivalent of worse than 20/32 and better than 20/630) at the screening visit and on day 1 Key Exclusion Criteria: 1. BCVA of ≤30 ETDRS letters (Snellen equivalent of 20/250 or worse) at the screening visit and/or on day 1 2. Intraocular Pressure (IOP) \<5 mm Hg at the screening visit and/or on day 1 3. IOP \>25 mm Hg on day 1. Participants are permitted to take IOP-lowering eye drops 4. Confirmed or suspected infectious uveitis, as defined in the protocol NOTE: Other Protocol-Defined Inclusion/Exclusion Criteria Apply